Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20141209020258N94Phase 3Completed
Phase 3 trial of caffeine and melatonin in post-dural puncture headache (PDPH) (2 arms), sponsored by Vice chancellor for research,Arak University of Medical Sciences. Primary endpoint: Incidence of post-spinal anesthesia headache. Started Jul 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20141209020258N94.